v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
Column | Value |
---|---|
Trial registration number | EUCTR2021-000701-24-NL |
Full text link
Last imported at : April 21, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
https://www.clinicaltrialsregister.eu/ctr-search/trial/2021-000701-24/NL |
First author
Last imported at : April 21, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
|
Contact
Last imported at : April 21, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
h.vanderkuy@erasmusmc.nl |
Registration date
Last imported at : April 21, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
2021-03-22 |
Recruitment status
Last imported at : April 21, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
Recruiting |
Study design
Last imported at : April 21, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
nonRCT |
Allocation
Last imported at : April 21, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
Non-randomized |
Design
Last imported at : April 21, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
Parallel |
Masking
Last imported at : April 21, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
Open label |
Center
Last imported at : April 21, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
single-center |
Study aim
Last imported at : April 21, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
Prevention |
Inclusion criteria
Last imported at : April 21, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
All HCW who work in the health care facility with at least one confirmed SARS CoV-2 infected patient receiving care and who have symptoms associated with SARS CoV-2. Alle zorgmedewerkers die minstens één bevestigde SARS-CoV-2 geïnfecteerde patiënt verzorgen die symptomen heeft geassocieerd met SARS-CoV-2 |
Exclusion criteria
Last imported at : April 21, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
1. HCW younger than 18 2. HCW that are pregnant or have a wish to become pregnant within 6 months 3. All regular contra-indications of the vaccines will be applied 1. Zorgmedewerkers jonger dan 18 jaar 2. Zorgmedewerkers die zwanger zijn of zwanger willen worden binnen 6 maanden 3. Alle reguliere contra-indicaties bij vaccinaties |
Number of arms
Last imported at : April 21, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
3 |
Funding
Last imported at : April 21, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
Erasmus MC |
Inclusion age min
Last imported at : April 21, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
18 |
Inclusion age max
Last imported at : April 21, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
64 |
Countries
Last imported at : April 21, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
Netherlands |
Type of patients
Last imported at : April 21, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
Health workers |
Severity scale
Last imported at : April 21, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
N/A |
Total sample size
Last imported at : April 21, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
600 |
primary outcome
Last imported at : April 21, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
Detection of immunity against SARS-CoV-2 Antistof respons tegen SARS-CoV-2 |
Notes
Last imported at : April 21, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
Dose 2 |
Phase
Last imported at : April 21, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
Phase 4 |
Arms
Last imported at : April 21, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
[{"arm_notes": "The comparator receive two identical vaccinations according to the label", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}, {"arm_notes": "ChAdOx1 (1st dose)+COVID-19 mRNA vaccine (2nd dose);1+1;heterologouse prime boost", "treatment_id": 1445, "treatment_name": "Chadox1 ncov-19+covid-19 mrna vaccine (nucleoside-modified)", "treatment_type": "Non replicating viral vector+rna based vaccine", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "COVID-19 mRNA vaccine (1st dose)+ChAdOx1 (2nd dose);1+1;heterologouse prime boost", "treatment_id": 1445, "treatment_name": "Chadox1 ncov-19+covid-19 mrna vaccine (nucleoside-modified)", "treatment_type": "Non replicating viral vector+rna based vaccine", "pharmacological_treatment": "Vaccine"}] |